|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 124,800.00 KRW | -0.48% |
|
-6.87% | +18.07% |
| 05-27 | HEALTH ROUNDS-Veracyte genomic test identifies breast cancer patients who can skip chemo | RE |
| 05-15 | ORION Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 4,933B 3.2B 2.81B 2.59B 2.42B 4.54B 302B 4.63B 31.09B 12.04B 149B 12.02B 11.76B 518B | P/E 2026 * |
10.3x | P/E 2027 * | 9.39x |
|---|---|---|---|---|---|
| Enterprise Value | 3.47B 2.25M 1.98M 1.82M 1.7M 3.2M 212M 3.25M 21.86M 8.47M 105M 8.46M 8.27M 364M | EV / Sales 2026 * |
0.94x | EV / Sales 2027 * | 0.81x |
| Free-Float |
56.16% | Yield 2026 * |
3.17% | Yield 2027 * | 3.34% |
| 1 day | -0.48% | ||
| 1 week | -6.87% | ||
| Current month | -3.70% | ||
| 1 month | -8.84% | ||
| 3 months | -6.94% | ||
| 6 months | +15.88% | ||
| Current year | +18.07% |
| 1 week | 120,300 |  | 134,200 |
| 1 month | 120,300 | | 139,700 |
| Current year | 102,000 | | 150,100 |
| 1 year | 99,000 | | 150,100 |
| 3 years | 81,800 | | 150,100 |
| 5 years | 80,200 | | 150,100 |
| 10 years | 75,700 | | 164,500 |
| Manager | Title | Age | Since |
|---|---|---|---|
Seung-Joon Lee
CEO | Chief Executive Officer | 66 | 01/01/2022 |
Cheol-Gon Tam
PRN | Corporate Officer/Principal | 71 | 01/04/1980 |
| Director | Title | Age | Since |
|---|---|---|---|
In-Cheol Heo
BRD | Director/Board Member | 66 | 01/07/2014 |
Wook Lee
BRD | Director/Board Member | 67 | 01/03/2020 |
Seung-Joon Lee
CHM | Chairman | 66 | 01/01/1994 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 08/01/25 | Others | 17 | 0.0000% | |||
| 20/05/24 | Others | 342 | 0.0009% | |||
| 20/05/24 | Others | 4,474 | 0.0113% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.48% | -6.87% | +14.92% | -0.40% | 3.2B | |
| +0.29% | +6.19% | +5.91% | -22.54% | 265B | |
| -0.87% | +1.80% | -9.04% | -16.28% | 78.56B | |
| +2.46% | +10.11% | +3.08% | +28.57% | 51B | |
| +1.26% | -0.93% | +142.59% | +468.37% | 40.86B | |
| -3.47% | +2.35% | +5.46% | -31.81% | 35.84B | |
| +1.94% | +1.92% | +46.35% | +4.99% | 36.89B | |
| -0.37% | -1.19% | +49.96% | +98.16% | 33.95B | |
| +1.52% | +0.20% | +16.70% | +24.65% | 28.67B | |
| +2.31% | +2.85% | -8.78% | -34.64% | 27.83B | |
| Average | +0.45% | +1.07% | +26.71% | +51.91% | 60.22B | |
| Weighted average by Cap. | +0.36% | +3.44% | +17.81% | +25.66% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3,701B 2.4B 2.11B 1.94B 1.82B 3.41B 227B 3.47B 23.33B 9.04B 112B 9.02B 8.82B 388B | 3,918B 2.54B 2.23B 2.06B 1.92B 3.61B 240B 3.68B 24.69B 9.56B 118B 9.55B 9.34B 411B |
| Net income | 480B 311M 274M 252M 236M 442M 29.39B 450M 3.02B 1.17B 14.49B 1.17B 1.14B 50.34B | 523B 340M 298M 275M 257M 482M 32.05B 491M 3.3B 1.28B 15.8B 1.28B 1.25B 54.9B |
| Net Debt | -1,464B -950M -835M -769M -719M -1.35B -89.66B -1.37B -9.23B -3.57B -44.2B -3.57B -3.49B -154B | -1,757B -1.14B -1B -923M -863M -1.62B -108B -1.65B -11.07B -4.29B -53.03B -4.28B -4.19B -184B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/06/26 | ₩124,800.00 | -0.48% | 149,856 |
| 24/06/26 | ₩125,400.00 | -0.08% | 112,839 |
| 23/06/26 | ₩125,500.00 | -3.54% | 140,505 |
| 22/06/26 | ₩130,100.00 | -2.91% | 69,842 |
| 19/06/26 | ₩134,000.00 | 0.00% | 120,950 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- A271560 Stock
Select your edition
All financial news and data tailored to specific country editions
